EDP-322
EDP-322-07-002
Phase 1 small_molecule completed
Quick answer
EDP-322 for MRSA, SSTI is a Phase 1 program (small_molecule) at ENANTA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ENANTA PHARMACEUTICALS INC
- Indication
- MRSA, SSTI
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed